Free Trial
NASDAQ:MGTX

MeiraGTx (MGTX) Stock Price, News & Analysis

MeiraGTx logo
$9.18 0.00 (0.00%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$9.08 -0.10 (-1.13%)
As of 09:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About MeiraGTx Stock (NASDAQ:MGTX)

Advanced

Key Stats

Today's Range
$8.60
▼
$9.28
50-Day Range
$8.51
▼
$13.89
52-Week Range
$6.62
▼
$15.35
Volume
732,221 shs
Average Volume
650,412 shs
Market Capitalization
$897.16 million
P/E Ratio
11.48
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Moderate Buy

Company Overview

MeiraGTx Holdings plc is a biotechnology company developing gene therapies for serious diseases with limited treatment options. Its research focuses on using adeno-associated virus (AAV) vectors to deliver genetic material to target cells, including in programs for inherited retinal diseases, neurological conditions and salivary gland dysfunction.

The company also develops manufacturing capabilities and technologies intended to support the production of gene therapies. MeiraGTx was founded in 2015 and has operations in the United States and the United Kingdom. Its chief executive officer is Alexandria Forbes, who co-founded the company.

AI Generated. May Contain Errors.

MeiraGTx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

MGTX MarketRank™: 
2.60664451827 of 5 stars

MeiraGTx scored higher than 52% of companies evaluated by MarketBeat, and ranked 512th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MeiraGTx has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    MeiraGTx has a consensus price target of $24.00, representing about 161.4% upside from its current price of $9.18.

  • Amount of Analyst Coverage

    MeiraGTx has only been the subject of 3 research reports in the past 90 days.

  • Read more about MeiraGTx's stock forecast and price target.
  • Earnings Growth

    Earnings for MeiraGTx are expected to decrease in the coming year, from $0.32 to ($2.01) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MeiraGTx is 11.48, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MeiraGTx is 11.48, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.59.

  • Percentage of Shares Shorted

    7.47% of the float of MeiraGTx has been sold short.
  • Short Interest Ratio / Days to Cover

    MeiraGTx has a short interest ratio ("days to cover") of 10.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in MeiraGTx has recently increased by 3.15%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    MeiraGTx does not currently pay a dividend.

  • Dividend Growth

    MeiraGTx does not have a long track record of dividend growth.

  • News Sentiment

    MeiraGTx has a news sentiment score of -0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for MeiraGTx this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for MGTX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,710,812.00 in company stock.

  • Percentage Held by Insiders

    7.40% of the stock of MeiraGTx is held by insiders.

  • Percentage Held by Institutions

    67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MeiraGTx's insider trading history.
Receive MGTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MGTX Stock News Headlines

MeiraGTx (NASDAQ:MGTX) Downgraded by Wall Street Zen to Hold
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
MeiraGTx (NASDAQ:MGTX) Stock Price Down 7.4% After Earnings Miss
MeiraGTx Q3 2026: Misses Matter Less Than the BLA Clock
MeiraGTx (MGTX) Projected to Announce Earnings on Thursday
See More Headlines

MGTX Stock Analysis - Frequently Asked Questions

MeiraGTx's stock was trading at $7.95 at the beginning of 2026. Since then, MGTX shares have increased by 15.5% and is now trading at $9.18.

MeiraGTx Holdings PLC (NASDAQ:MGTX) issued its earnings results on Thursday, November, 12th. The company reported ($0.53) earnings per share for the quarter, missing analysts' consensus estimates of ($0.50) by $0.03. The firm had revenue of $4.81 million for the quarter, compared to the consensus estimate of $6.95 million. MeiraGTx had a trailing twelve-month return on equity of 85.23% and a net margin of 19.46%.

MeiraGTx (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager.

Top institutional investors of MeiraGTx include State Street Corp (1.48%), Assenagon Asset Management S.A. (0.23%), Privium Fund Management B.V. (0.22%) and Alps Advisors Inc. (0.18%). Insiders that own company stock include Perceptive Advisors Llc, Alexandria Forbes, Richard Giroux and Stuart Naylor.
View institutional ownership trends
.

Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Micron Technology (MU), Novavax (NVAX) and PayPal (PYPL).

Company Calendar

Last Earnings
11/12/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:MGTX
CIK
1735438
Fax
N/A
Employees
393
Year Founded
2015

Price Target and Rating

High Price Target
$35.00
Low Price Target
$16.00
Potential Upside/Downside
+161.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.80
Trailing P/E Ratio
11.48
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$114.20 million
Net Margins
19.46%
Pretax Margin
20.19%
Return on Equity
85.23%
Return on Assets
24.12%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
4.62
Quick Ratio
4.62

Sales & Book Value

Annual Sales
$81.39 million
Price / Sales
11.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-131.14

Miscellaneous

Outstanding Shares
97,730,000
Free Float
90,499,000
Market Cap
$897.16 million
Optionable
Optionable
Beta
1.09

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:MGTX) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners